Central Macular Thickness Monitoring after a Taxane-Based Therapy in Visually Asymptomatic Patients

Abstract

Taxane-based chemotherapy regimens seem to increase macular thickness, with a relative sparing of the fovea, in patients without significant macular edema. Further research is required to better explain the pathophysiology and possible impact of this phenomenon.